University of Patras
Ο ρόλος της θρομβίνης και των υποδοχέων της στην αγγειογένεση και στην ανάπτυξη και μετάσταση του καρκίνου
Abstract
dc:descriptionFrom the onset of studies of PAR1, it has been concluded that this receptor is closely related to cancer. This relationship has been established after various experiments in cancer cell lines and in experimental animal models. The purposes of the present study can be summarized as follows: To explore the expression of PAR1 in cell lines established from human solid tumors and specifically PC3 and LNCaP from prostate cancer and MDA-231 and MCF-7 from breast cancer. To explore the suppression of PAR1 to the above cell lines in cell division. To determine if the activation of PAR1 to the above cell lines leads to MAPK phosphorylation. And ultimately, to explore the expression of PAR1 in patients that have been operated for tumor in lungs in Patras University Hospital by Dr. D. Dougenis and colleagues. It was found that PAR1 is strongly expressed in highly metastatic cell lines PC3 and MDA-231, opposite to the cells LNCaP and MCF-7 that have lower metastatic capacity. The finding for the breast cancer cells MDA-231 and MCF-7 was according to published results (Kamath et al., 2001). PAR1 selective antagonist SCH 79797, reduced cell survival and DNA synthesis to all the above mentioned cell lines, independently of PAR1 expression. These non-specific results contributed to the recent fact that these antagonists were not PAR1 selective finally. Thrombin caused more than 100% induction of DNA synthesis in PC3 cells and had no effect in MDA-231 cells in accordance with published results that thrombin reduces the metastatic capacity of MDA-231 cells (Kamath et al., 2001). This effect of thrombin in PC3 cells, is mediated by activation of PAR1 as it was shown with the use of the selective agonist peptide SFLLRN. The activation of PAR1 by thrombin in PC3 cells leads to MAPK activation as it was shown by Western analysis. Furthermore, preliminary experiments indicate that MAPK phosphorylation after PAR1 activation may be result of EGFR transactivation. In the sample tissues from patients, PAR1 expression was detected in all cancers with different ODs. The number of the samples is not enough to lead to conclusions, but there are some important observations. The highest level of PAR1 expression as was detected by RT-PCR were found to the sample tissues of the patient diagnosed for melanoma and of the patient with the most advanced stage of lung cancer. More patients should be examined and more experiments to be done in order to proceed to conclusions for the significance of PAR1 in lung cancer.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Κρητικού, Σωσάννα
- Kritikou, Sosanna
Subjects
dc:subject × 23- Θρομβίνη
- Πρωτεολυτικός ενεργοποιούμενος υποδοχέας θρομβίνης 1
- Καρκίνος
- Μετάσταση
- Ανθρώπινες καρκινικές σειρές
- Καρκίνος του πνεύμονα
- Ανταγωνιστής του PAR-1
- Thrombin
- PAR-1
- Lung cancer
- PC3
- LNCAP
- MDA-231-MB
- MCF-7
- PAR-1 antagonist SCH 79797
- Φυσικές Επιστήμες
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Natural Sciences
- Biological Sciences
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28395